Immunomodulatory properties of Lung Resident Mesenchymal Stem Cells in patients with COPD

T. Cruz (Barcelona, Spain), A. López-Giraldo (Barcelona, Spain), G. Noell (Barcelona, Spain), A. Agusti (Barcelona, Spain), M. Faner Canet (Barcelona, Spain)

Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Session: Regenerative and anti-fibrotic approaches
Session type: Poster Discussion
Number: 585
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Cruz (Barcelona, Spain), A. López-Giraldo (Barcelona, Spain), G. Noell (Barcelona, Spain), A. Agusti (Barcelona, Spain), M. Faner Canet (Barcelona, Spain). Immunomodulatory properties of Lung Resident Mesenchymal Stem Cells in patients with COPD. 585

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Characterization of Mesenchymal Stem Cells obtained from human lungs with and without Idiopathic Pulmonary Fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019

Mechanical Preconditioning of Lung Mesenchymal Stem Cells Improves Ventilation Induced Lung Injury in Rats
Source: International Congress 2018 – Triggers of acute lung injury: mechanical ventilation and oxygen levels
Year: 2018

Pulmonary Complications After Hematopoietic Stem Cell Transplantation In Pediatric Hematology Patients
Source: International Congress 2018 – Orphan diseases in children
Year: 2018



Lung Cancer Stem Cells From Lymph Nodes Aspirates Express Immunosuppressive Molecules
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021


Differentiation of Induced Pluripotent Stem Cells (iPSC) into human bronchial epithelium from healthy and severe COPD patients.
Source: International Congress 2018 – A fresh view on airway differentiation and regeneration
Year: 2018



Physiological and Immunological Effects of Naïve and Pre-Activated Mesenchymal Stromal Cells in Klebsiella Pneumoniae-Induced Sepsis in Rats
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020


Mesenchymal Stromal Cells Modulate the Systemic and Pulmonary Immune Cell Profile in Klebsiella Pneumoniae Induced Sepsis
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020


Use of Airway Epithelial Cell Cultures in Inflammatory Lung Disease Research
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009

A Reduced Frequency of GARPFoxp3 T Regulatory Cells in COPD Patients is Associated with Emphysema Phenotype
Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD
Year: 2021


Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Disease 2019
Source: ERJ Open Res, 6 (4) 00123-2020; 10.1183/23120541.00123-2020
Year: 2020



LSC - 2017 - Reprogramming Of Tumor Associated Macrophages By Modulating Wnt/ß-catenin Signalling In Lung Cancer.
Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Year: 2017



The Effect of Cordycepin and Simvastatin on Cigarettes Smoke Extract Induced Cytokine and Chemokine Production in Human Bronchial Epithelial Cells
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018


Effects of extracellular vesicles from mesenchymal stromal cells in experimental silicosis
Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Year: 2014

Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer
Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology
Year: 2019

Mast Cell Tryptase Enhances Wound-Healing via Protease-Activated Receptor-2 Dependent Migration in Human Bronchial Epithelial Cells
Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair
Year: 2021



Intratracheal application of healthy lung derived Mesenchymal Stem Cells (DON-MSC) in the form of biospheres (BS) as potential therapeutic agents for chronic lung disease
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020

Comparison of Exercise Capacity Respiratory Muscle Strength and Depression in Non-Small Cell Lung Cancer Patients and Healthy Controls
Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases
Year: 2020


Pharmacological Rescue of Conventional Primary Equine Bronchial Epithelial Cells
Source: International Congress 2017 – Therapeutic approaches in lung disease
Year: 2017

Late Breaking Abstract - Activation of Notch1 signalling promotes Bone Marrow-derived Mesenchymal Stem Cells proliferation, migration and survival in COPD microenvironment via PI3K/Akt
Source: International Congress 2017 – Update and new perspectives in Airway Diseases
Year: 2017

Effects of Sustained and Intermittent Hypoxia on Human Lung Cancer Cells
Source: International Congress 2019 – Insights into the pathophysiology of sleep-disordered breathing
Year: 2019